Regulatory Pathways
Regulatory Pathways is a structured framework of statutory, administrative, and procedural routes that governs how emerging technologies and their associated products obtain requisite approvals, certifications, and market access permissions from relevant regulatory authorities within a given jurisdiction.
27
Publications
1.7K
Citations
125
Authors
84
Institutions
Publications per year
2017–2026
6
27
Developing the Nation's Biosimilars Program
Steven Kozlowski, Janet Woodcock, Karen Midthun et al. · New England Journal of Medicine · 2011 · 196 citations
Pharmacy, Pharmaceutical Policy, Drug Approval Processes +15
Putative cis-regulatory drivers in colorectal cancer
Halit Ongen, Claus L. Andersen, Jesper B. Bramsen et al. · Nature · 2014 · 151 citations
Medicine, Cancer Biology, Oncology +14
1–5 of 27
125
2
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 125
84
University of Geneva
Geneva, Switzerland
2 h-index
8 publications
1.1K citations

Centre National de la Recherche Scientifique
Paris, France
2 h-index
7 publications
875 citations
Center for Drug Evaluation and Research
Silver Spring, United States
2 h-index
5 publications
446 citations
Harvard University
Cambridge, United States
2 h-index
2 publications
22 citations

Johns Hopkins University
Baltimore, United States
2 h-index
9 publications
391 citations
Utrecht University
Utrecht, The Netherlands
2 h-index
5 publications
129 citations

Harvard University Press
Cambridge, United States
2 h-index
2 publications
28 citations
Centre for Innovation in Regulatory Science
London, United Kingdom
2 h-index
3 publications
54 citations
1–8 of 84
2 publications · 194 citations
2
h-index
Repository · 2 publications · 84 citations
2
h-index
1 publications · 10 citations
1
h-index
1 publications · 21 citations
1
h-index
1 publications · 12 citations
1
h-index
1–5